↓ Skip to main content

Single dose oral celecoxib for acute postoperative pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
1 policy source
twitter
13 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Single dose oral celecoxib for acute postoperative pain in adults
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd004233.pub4
Pubmed ID
Authors

Sheena Derry, R Andrew Moore

Abstract

This is an update of a review first published in The Cochrane Library in Issue 4, 2008, and updated in Issue 3, 2012. Celecoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor usually prescribed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis. Celecoxib is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs). Its effectiveness in acute pain was demonstrated in the earlier reviews.

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Brazil 1 <1%
Italy 1 <1%
Canada 1 <1%
Malaysia 1 <1%
Unknown 105 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 20%
Other 14 13%
Student > Bachelor 13 12%
Student > Ph. D. Student 12 11%
Researcher 11 10%
Other 24 22%
Unknown 15 14%
Readers by discipline Count As %
Medicine and Dentistry 63 57%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Agricultural and Biological Sciences 5 5%
Neuroscience 2 2%
Other 9 8%
Unknown 18 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2020.
All research outputs
#1,296,060
of 14,794,860 outputs
Outputs from Cochrane database of systematic reviews
#3,612
of 11,057 outputs
Outputs of similar age
#18,244
of 183,973 outputs
Outputs of similar age from Cochrane database of systematic reviews
#35
of 105 outputs
Altmetric has tracked 14,794,860 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,057 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,973 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.